Rodger Novak

Venture Partner

Rodger is a Venture Partner based in Switzerland supporting SR One on new company formation and early-stage investment. Rodger is a serial entrepreneur, long-time pharmaceutical and biotechnology senior executive. In 2013 he co-founded CRISPR Therapeutics, led the team that IPO’d the company in 2016 and led CRISPR as CEO until December 2017. Rod...


Roles at SR One Capital Management

  • Venture Partner

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.